Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (1256)	1/22/1998 4:04:00 PM
From: Frank Buck	Respond to of 1894

Sigmund, Let's face it, car manufacturers still sell many manual transmission vehicles in spite of the ease of an automatic transmission. Economics probably play a bigger role in that than nostalgia. The JAMA Report seems to be indicating...the old system wasn't broke, but certain manufacturers tried to fix it anyway. AccuMed never said the system was broke, but saw where it could be improved. The cost to labor benefit analysis appeal, (such as AccuMed has done with the Detroit Lab Study) currently seems the best way to crack this nut. The economics of employing this new piece of capital-equipment will have to irrefutably show it would be financial suicide not to employ it. Education, education, education. The multi-city cytology conferences are a good start. I think we can all agree that the system doesn't sell itself like many previous shareholders had figured it would. I agree what is bad for one is bad for all. They are presently all joined at the hip. Frank